Telescope Implant for End Stage AMD Approved by Medicaire

VisionCare Ophthalmic Technologies, Inc., developer of the first FDA-approved ophthalmic telescope implant indicated to improve vision in patients with end-stage age-related macular degeneration (AMD), announced today the expansion of its CentraSight(TM) provider teams nationwide. VisionCare’s telescope implant is integral to the CentraSight treatment program ( http://www.CentraSight.com ), which helps patients follow the steps necessary for proper diagnosis, surgical evaluation and postoperative care. The telescope implant improves visual acuity and quality of life for those living with the most severe form of AMD and can help seniors become more independent and re-engage in everyday activities.

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/telescope-implant-for-end-stage-macular-degeneration-now-available-across-the-nation-157936385.html

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: